Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prehospital intravenous Augmentin for severe sepsis
NL-OMON29015Recruiting
- Sponsor
- Albert Schweitzer Hospital
- Start
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of amoxicillin + clavulanate in sepsis (2 arms), sponsored by Albert Schweitzer Hospital. Primary endpoint: Mortality reduction in patients with severe sepsis. Started Nov 2012; status: recruiting.
02
Drugs
amoxicillin + clavulanate
03
Conditions
sepsis
Beyond the preview
Go deeper on NL-OMON29015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29015.